Researchers attribute the drop to an intensely competitive market for medical technology.
The following categories of devices saw price declines:
• Drug-eluting stents — 34 percent
• Artificial hips — 23 percent
• Artificial knees — 17 percent
• Implantable defibrillators — 24 percent
• Bare metal stents — 27 percent
More Articles on Devices:
7 Key Notes on Spine & Orthopedic Device Companies
6 New Spine, Orthopedic Device Launches & Approvals
Dr. William Geissler Implants First Integra LifeSciences’ Titan Reverse Shoulder System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
